28 results on '"Kamper, Peter"'
Search Results
2. Pulmonary diseases in patients with classical Hodgkin lymphoma relative to a matched background population: A Danish national cohort study.
3. One-year mortality among non-surgical patients with hematological malignancies admitted to the intensive care unit: a Danish nationwide population-based cohort study
4. Machine Learning–Based Survival Prediction Models for Progression-Free and Overall Survival in Advanced-Stage Hodgkin Lymphoma.
5. The Genetic Profile of Large B-Cell Lymphomas Presenting in the Ocular Adnexa.
6. The combined role of biomarkers and interim PET scan in prediction of treatment outcome in classical Hodgkin's lymphoma: a retrospective, European, multicentre cohort study
7. Proteomic analysis identifies galectin-1 as a predictive biomarker for relapsed/refractory disease in classical Hodgkin lymphoma
8. Tumour-associated mast cells in classical Hodgkinʼs lymphoma: correlation with histological subtype, other tumour-infiltrating inflammatory cell subsets and outcome
9. Relationship of intratumoural protein expression patterns to age and Epstein-Barr virus status in classical Hodgkin lymphoma
10. Identification of homozygous deletion in ACAN and other candidate variants in familial classical Hodgkin lymphoma by exome sequencing
11. Factors associated with risk and prognosis of intensive care unit admission in patients with acute leukemia: a Danish nationwide cohort study.
12. Late recurrence of lymphoid malignancies after initial treatment for Hodgkin lymphoma – A study from the Danish Lymphoma Registry.
13. Parenthood Rates and Use of Assisted Reproductive Techniques in Younger Hodgkin Lymphoma Survivors: A Danish Population-Based Study.
14. Epstein-Barr virus-associated familial Hodgkin lymphoma: paediatric onset in three of five siblings
15. Ocular adnexal lymphoma in Denmark: a nationwide study of 387 cases from 1980 to 2017.
16. Soluble programmed cell death protein 1 (sPD‐1) and the soluble programmed cell death ligands 1 and 2 (sPD‐L1 and sPD‐L2) in lymphoid malignancies.
17. Salvage Therapy in Early Relapse of T-Lymphoblastic Leukemia/Lymphoma Using Daratumumab/Nelarabine Combination: Two Consecutive Cases.
18. Distribution of hospital care among pediatric and young adult Hodgkin lymphoma survivors—A population‐based cohort study from Sweden and Denmark.
19. Focal skeletal FDG uptake indicates poor prognosis in cHL regardless of extent and first‐line chemotherapy.
20. The incidence of bleomycin induced lung toxicity is increased in Hodgkin lymphoma patients over 45 years exposed to granulocyte-colony stimulating growth factor.
21. Hodgkin lymphoma in children, adolescents and young adults - a comparative study of clinical presentation and treatment outcome.
22. Prognostic Model to Predict Post-Autologous Stem-Cell Transplantation Outcomes in Classical Hodgkin Lymphoma.
23. T082: AVD ‐ a possible golden standard in the first‐line treatment of older classical Hodgkin lymphoma patients.
24. Classical Hodgkin Lymphoma Presenting with Severe, Recurrent Hypothermic Episodes.
25. P074: Long‐Term Cause‐Specific Mortality in Hodgkin Lymphoma Patients – A Nationwide Danish Cohort Study.
26. Impact of 18F-fluorodeoxyglucose positron emission tomography/computed tomography staging in newly diagnosed classical Hodgkin lymphoma: fewer cases with stage I disease and more with skeletal involvement.
27. Classic Hodgkin Lymphoma Refractory for ABVD Treatment Is Characterized by Pathologically Activated Signal Transduction Pathways as Revealed by Proteomic Profiling.
28. Long‐term cause‐specific mortality in adolescent and young adult Hodgkin lymphoma patients treated with contemporary regimens—A nationwide Danish cohort study.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.